Literature DB >> 3066652

Glucose disposal in obese non-diabetic and diabetic type II patients. A study by indirect calorimetry and euglycemic insulin clamp.

A Golay1, R A Defronzo, D Thorin, E Jequier, J P Felber.   

Abstract

Insulin resistance is a characteristic finding in obesity and in non insulin dependent (Type II) diabetes mellitus. However, the interaction between diabetes and obesity has been poorly characterized and the metabolic disturbances contributing to the defect in insulin-mediated glucose uptake have not been defined. To examine these questions euglycemic and hyperinsulinemic clamp studies (40 mU/m2/min) were performed in 10 control non-obese subjects, 10 non diabetic obese subjects, 8 normal weight Type II diabetics, and 12 obese Type II diabetics. During the insulin clamp study total body glucose uptake in the obese non diabetics (157 +/- 18 mg/m2.min, p less than 0.01), the normal weight diabetics (159 +/- 21, p less than 0.01) and the obese diabetics (125 +/- 11, p less than 0.001) was significantly reduced compared to the non-obese non diabetic control group (249 +/- 22 mg/m2.min). The impairment in total body glucose uptake was the result mainly of a defect in non-oxidative glucose disposal. Indeed non-oxidative glucose disposal was blunted by 50% in the obese groups (p less than 0.01), somewhat less significantly in the non-obese diabetic group (p less than 0.05) but more when obesity and diabetes mellitus were combined (p less than 0.001). Total glucose oxidation was significantly diminished (p less than 0.01) in both diabetic groups but not in the obese non diabetic group when compared to lean control. A significant inverse correlation between the fasting free fatty acids levels and total glucose uptake (r = -0.453, p less than 0.001) and total glucose oxidation (r = -0.446, p less than 0.001) during the clamp was observed.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3066652

Source DB:  PubMed          Journal:  Diabete Metab        ISSN: 0338-1684


  5 in total

1.  Metabolic Evidence of Diminished Lipid Oxidation in Women With Polycystic Ovary Syndrome.

Authors:  Leah D Whigham; Daniel E Butz; Hesam Dashti; Marco Tonelli; Luann K Johnson; Mark E Cook; Warren P Porter; Hamid R Eghbalnia; John L Markley; Steven R Lindheim; Dale A Schoeller; David H Abbott; Fariba M Assadi-Porter
Journal:  Curr Metabolomics       Date:  2014

2.  Reduced glycogen synthase activity in skeletal muscle from obese patients with and without type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  P Damsbo; A Vaag; O Hother-Nielsen; H Beck-Nielsen
Journal:  Diabetologia       Date:  1991-04       Impact factor: 10.122

Review 3.  Treating diabetes and prediabetes by focusing on obesity management.

Authors:  Lalita Khaodhiar; Sue Cummings; Caroline M Apovian
Journal:  Curr Diab Rep       Date:  2009-10       Impact factor: 4.810

4.  Relationships between mitochondrial function and metabolic flexibility in type 2 diabetes mellitus.

Authors:  Tineke van de Weijer; Lauren Marie Sparks; Esther Phielix; Ruth Carla Meex; Noud Antonius van Herpen; Matthijs Karel C Hesselink; Patrick Schrauwen; Vera Bettina Schrauwen-Hinderling
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

5.  Reduced adipose tissue macrophage content is associated with improved insulin sensitivity in thiazolidinedione-treated diabetic humans.

Authors:  Sudha Koppaka; Sylvia Kehlenbrink; Michelle Carey; Weijie Li; Elizabeth Sanchez; Do-Eun Lee; Hanna Lee; Julie Chen; Emilce Carrasco; Preeti Kishore; Kehao Zhang; Meredith Hawkins
Journal:  Diabetes       Date:  2013-01-24       Impact factor: 9.461

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.